S
Stefan Mellander
Researcher at Lund University
Publications - 65
Citations - 3290
Stefan Mellander is an academic researcher from Lund University. The author has contributed to research in topics: Microcirculation & Vascular resistance. The author has an hindex of 31, co-authored 65 publications receiving 3195 citations. Previous affiliations of Stefan Mellander include University of Gothenburg & Hammersmith Hospital.
Papers
More filters
Journal Article
Control of resistance, exchange, and capacitance functions in the peripheral circulation
Stefan Mellander,Börje Johansson +1 more
Journal ArticleDOI
Fluid transfer between blood and tissues during exercise.
TL;DR: The investigations suggested that at least half of the fluid gain to the circulatory system in heavy exercise could be ascribed to the increased arterial osmolality and the remainder to a reflex decrease of capillary pressure.
Journal ArticleDOI
Vascular Adjustments to Increased Transmural Pressure in Cat and Man with Special Reference to Shifts in Capillary Fluid Transfer
TL;DR: The vascular rejponse parterns described are evidently brought into play mainly by a reinforcement of the local inherent automaticity of the vascular smooth muscle induced by the raised trans.
Journal ArticleDOI
Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease.
Joakim Nordanstig,Stefan James,Manne Andersson,Mattias K Andersson,Peter Danielsson,Peter Gillgren,Martin Delle,Jan Engström,Torbjörn Fransson,Maher Hamoud,Anna Hilbertson,Patrik Johansson,Lars Karlsson,Björn Kragsterman,Hans Lindgren,Karin Ludwigs,Stefan Mellander,Niklas Nyman,Henrik Renlund,Birgitta Sigvant,Per Skoog,Joachim Starck,Gustaf Tegler,Asko Toivola,Maria Truedson,Carl Magnus Wahlgren,Jonas Wallinder,Andreas Öjersjö,Mårten Falkenberg +28 more
TL;DR: In this randomized trial in which patients with peripheral artery disease received treatment with paclitaxel-coated or uncoated endovascular devices, the results of an unplanned interim analysis of all-cause mortality did not show a difference between the groups in the incidence of death during 1 to 4 years of follow-up.